Epigenetic age acceleration in the emerging burden of cardiometabolic diseases among migrant and non-migrant African populations: the population based cross-sectional RODAM study.


Journal

The lancet. Healthy longevity
ISSN: 2666-7568
Titre abrégé: Lancet Healthy Longev
Pays: England
ID NLM: 101773309

Informations de publication

Date de publication:
17 05 2021
Historique:
entrez: 11 2 2022
pubmed: 12 2 2022
medline: 12 2 2022
Statut: ppublish

Résumé

African populations are experiencing health transitions due to rapid urbanization and international migration. However, the role of biological aging in this emerging burden of cardiometabolic diseases (CMD) among migrant and non-migrant Africans is unknown. We aimed to examine differences in epigenetic age acceleration (EAA) as measured by four clocks (Horvath, Hannum, PhenoAge and GrimAge) and their associations with cardiometabolic factors among migrant Ghanaians in Europe and non-migrant Ghanaians. Genome-wide DNA methylation (DNAm) data of 712 Ghanaians from cross-sectional RODAM study were used to quantify EAA. We assessed correlation of DNAmAge measures with chronological age, and then performed linear regressions to determine associations of body mass index (BMI), fasting blood glucose (FBG), blood pressure, alcohol consumption, smoking, physical activity, and one-carbon metabolism nutrients with EAA among migrant and non-migrants. We replicated our findings among 172 rural-urban sibling pairs from India migration study and among 120 native South Africans from PURE-SA-NW study. We found that Ghanaian migrants have lower EAA than non-migrants. Within migrants, higher FBG was positively associated with EAA measures. Within non-migrants, higher BMI, and Vitamin B9 (folate) intake were negatively associated with EAA measures. Our findings on FBG, BMI and folate were replicated in the independent cohorts. Our study shows that migration is negatively associated with EAA among Ghanaians. Moreover, cardiometabolic factors are differentially associated with EAA within migrant and non-migrant subgroups. Our results call for context-based interventions for CMD among transitioning populations that account for effects of biological aging. European Commission.

Sections du résumé

BACKGROUND
African populations are experiencing health transitions due to rapid urbanization and international migration. However, the role of biological aging in this emerging burden of cardiometabolic diseases (CMD) among migrant and non-migrant Africans is unknown. We aimed to examine differences in epigenetic age acceleration (EAA) as measured by four clocks (Horvath, Hannum, PhenoAge and GrimAge) and their associations with cardiometabolic factors among migrant Ghanaians in Europe and non-migrant Ghanaians.
METHODS
Genome-wide DNA methylation (DNAm) data of 712 Ghanaians from cross-sectional RODAM study were used to quantify EAA. We assessed correlation of DNAmAge measures with chronological age, and then performed linear regressions to determine associations of body mass index (BMI), fasting blood glucose (FBG), blood pressure, alcohol consumption, smoking, physical activity, and one-carbon metabolism nutrients with EAA among migrant and non-migrants. We replicated our findings among 172 rural-urban sibling pairs from India migration study and among 120 native South Africans from PURE-SA-NW study.
FINDINGS
We found that Ghanaian migrants have lower EAA than non-migrants. Within migrants, higher FBG was positively associated with EAA measures. Within non-migrants, higher BMI, and Vitamin B9 (folate) intake were negatively associated with EAA measures. Our findings on FBG, BMI and folate were replicated in the independent cohorts.
INTERPRETATION
Our study shows that migration is negatively associated with EAA among Ghanaians. Moreover, cardiometabolic factors are differentially associated with EAA within migrant and non-migrant subgroups. Our results call for context-based interventions for CMD among transitioning populations that account for effects of biological aging.
FUNDING
European Commission.

Identifiants

pubmed: 35146471
doi: 10.1016/S2666-7568(21)00087-8
pmc: PMC7612337
mid: EMS141013
doi:

Substances chimiques

Folic Acid 935E97BOY8

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

E327-E339

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/5
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : ZIA HG200362
Pays : United States

Commentaires et corrections

Type : CommentIn

Déclaration de conflit d'intérêts

Declarations of interests We declare no competing interests.

Références

Aging (Albany NY). 2015 Sep;7(9):690-700
pubmed: 26411804
J Nutr Biochem. 2006 Apr;17(4):250-6
pubmed: 16109485
Genome Biol. 2016 Aug 11;17(1):171
pubmed: 27511193
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Obesity (Silver Spring). 2020 Dec;28(12):2414-2423
pubmed: 33070472
Int J Epidemiol. 2019 Dec 1;48(6):1850-1862
pubmed: 31603469
Nutr Cancer. 2000;37(2):245-51
pubmed: 11142099
FASEB J. 2009 May;23(5):1521-8
pubmed: 19126595
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Nat Rev Genet. 2018 Jun;19(6):371-384
pubmed: 29643443
World J Surg. 2018 Jun;42(6):1617-1628
pubmed: 29234849
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Nature. 2020 Dec;588(7836):124-129
pubmed: 33268865
Aging (Albany NY). 2018 Apr 18;10(4):573-591
pubmed: 29676998
Int J Environ Res Public Health. 2019 Aug 28;16(17):
pubmed: 31466396
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Mol Cell. 2013 Jan 24;49(2):359-367
pubmed: 23177740
Lancet. 2013 Apr 6;381(9873):1235-45
pubmed: 23541058
BMC Med. 2016 Oct 21;14(1):166
pubmed: 27769239
BMC Public Health. 2019 Mar 21;19(1):327
pubmed: 30898125
Eur J Prev Cardiol. 2020 Mar;27(4):394-406
pubmed: 31408370
Aging (Albany NY). 2017 Feb 14;9(2):419-446
pubmed: 28198702
Cardiol Clin. 2017 Feb;35(1):71-86
pubmed: 27886791
Lancet Glob Health. 2015 Mar;3(3):e132-42
pubmed: 25701991
Clin Epigenetics. 2020 Jan 7;12(1):6
pubmed: 31910897
Am J Public Health. 1992 Jun;82(6):816-20
pubmed: 1585961
PLoS Med. 2010 Apr 27;7(4):e1000268
pubmed: 20436961
Genome Biol. 2015 Jan 30;16:25
pubmed: 25633388
Aging (Albany NY). 2019 Jan 21;11(2):303-327
pubmed: 30669119
FASEB J. 1998 Nov;12(14):1491-7
pubmed: 9806758
Genome Biol. 2013;14(10):R115
pubmed: 24138928
J Nutr Biochem. 2012 Aug;23(8):853-9
pubmed: 22749138
Aging (Albany NY). 2019 Apr 14;11(7):2045-2070
pubmed: 31009935

Auteurs

Felix P Chilunga (FP)

Department of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.

Peter Henneman (P)

Department of Clinical Genetics, Amsterdam Reproduction & Development research institute, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.

Hannah R Elliott (HR)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Department of population health sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

H Toinét Cronjé (HT)

Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark; Centre of Excellence for Nutrition, North-West University, Potchefstroom, South Africa.

Gagandeep K Walia (GK)

Public Health Foundation of India, New Delhi, India.

Karlijn A C Meeks (KAC)

Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Ana Requena-Mendez (A)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Department of Global Public Health, Karolinska Institutet, Solna, Sweden.

Andrea Venema (A)

Department of Clinical Genetics, Amsterdam Reproduction & Development research institute, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.

Silver Bahendeka (S)

Department of Medicine, MKPGMS-Uganda Martyrs University, Kampala, Uganda.

Ina Danquah (I)

Heidelberg Institute of Global Health (HIGH), Universitätsklinikum Heidelberg, Heidelberg, Germany.

Adebowale Adeyemo (A)

Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Kerstin Klipstein-Grobusch (K)

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherland; Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Marlien Pieters (M)

Medical Research Council Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.

Marcels M A M Mannens (MMAM)

Department of Clinical Genetics, Amsterdam Reproduction & Development research institute, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.

Charles Agyemang (C)

Department of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH